Home > Publications > Medical Specialty > Neurology > Multiple Sclerosis > Multiple Sclerosis Research Review, Issue 81
Multiple Sclerosis Research Review, Issue 81

Multiple Sclerosis Research Review, Issue 81

In this issue:

Ocrelizumab dose reduction in RRMS
Spinal cord lesion formation with DMTs in relapse-onset MS
EvolutionRMS1/2 trials: evobrutinib in relapsing MS
CVS, CL & PRL for diagnosis of MS
Disease activity & neonate outcomes with natalizumab in pregnancy
DMTs & disability worsening in paediatric-onset MS
Serologic responses to EBV peptides & MS risk
Healthy lifestyle behaviours & health outcomes in MS
Baseline sNfL levels to predict aggressive/benign RRMS
MS disease activity in pregnancy after cladribine

You need to be logged in to access this content.

Todd Hardy Photo 20231207

Expert contributor

Clinical Professor Todd Hardy

Clinical Professor Todd Hardy is Staff Specialist Neurologist at Concord Hospital, Clinical Senior Lecturer in Medicine at the University of Sydney and Co-Director of the MS Clinic at the Brain & Mind Centre. Dr Hardy’s clinical and research interests are in the field of neuroimmunology. His main focus is on multiple sclerosis, including atypical forms […]

Latest Publications and Videos

Stay up to date with our latest clinical information.

Explore Research Review Publications and Videos

Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry. 

Find Reviews in Your Clinical Area
Please select your country of practice.

It looks like you are closest to our New Zealand site.

Terms and Conditions

Website terms of use 

By using our website, you agree to follow these terms and conditions. 

 

Privacy policy 

We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms. 

 

Copyright and use of website content 

The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use. 

You cannot:  copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission. 

 

Links to third-party websites 

The Research Review website may link to third-party websites for your convenience. However: 

We do not endorse or approve their products, services, or actions. 

We are not responsible for their content or how they operate. 

There is no formal partnership between us and third parties unless we clearly state otherwise. 

 

Disclaimer and limitation of liability 

We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date. 

To the fullest extent allowed by law, we are not responsible for: 

Any loss, damage, or costs you may suffer from using (or being unable to use) our website. 

Any decisions you make based on the information provided. 

Any business losses, such as lost profits, lost data, or business interruptions. 

 

Governing law 

These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.